Screening for Chronic Obstructive Pulmonary Disease Using Spirometry: Summary of the Evidence for the U.S. Preventive Services Task Force

  1. Kenneth Lin, MD;
  2. Bradley Watkins, MD;
  3. Tamara Johnson, MD, MS;
  4. Joy Anne Rodriguez, MD, MPH; and
  5. Mary B. Barton, MD, MPP
  1. From the Center for Primary Care, Prevention, and Clinical Partnerships, Agency for Healthcare Research and Quality, Rockville, Maryland; Washington DC Veterans Affairs Medical Center, Washington, D.C.; University of Maryland School of Medicine, Baltimore, Maryland; and Brooks Air Force Base, Brooks City-Base, Texas.
    1. Figure 1.
      View larger version:
      Figure 1. Analytic framework for screening for chronic obstructive pulmonary disease (COPD) using spirometry.

      M/M = morbidity and mortality.

    2. Figure 2.
      View larger version:
      Figure 2. Projected outcomes of population-based screening for chronic obstructive pulmonary disease (COPD) using spirometry in current smokers age 40 years or older.

      NHANES = National Health and Nutrition Examination Survey.

    3. Appendix Figure 1.
      View larger version:
      Appendix Figure 1. Study flow diagram: key question 3.

      COPD = chronic obstructive pulmonary disease.

    4. Appendix Figure 2.
      View larger version:
      Appendix Figure 2. Study flow diagram: key question 4.
    5. Appendix Figure 3.
      View larger version:
      Appendix Figure 3. Study flow diagram: key question 6.

    Responses to this article

    • Definition of FEV1
      • Masashi Izumiya
      Ann Intern Med published online October 26, 2009
    « Previous | Next Article »Table of Contents

    This Article

    1. Ann Intern Med April 1, 2008 vol. 148 no. 7 535-543
    1. AbstractFREE
    2. » Figures
    3. Full Text
    4. Full Text (PDF)
    5. Recommendation Summary

    Current Issue

    1. November 3, 2009, 151 (9)
    1. Alert me to current issues